| 前收市價 | 4.9000 |
| 開市 | 4.9000 |
| 買盤 | 1.5000 |
| 賣出價 | 5.6000 |
| 拍板 | 25.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 4.9000 - 4.9000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 25 |
ZacksBeam Therapeutics (BEAM) Begins Dosing in Phase I/II AATD Study
Beam Therapeutics (BEAM) doses the first patient in a phase I/II study, evaluating in vivo base editor BEAM-302 for treating alpha-1 antitrypsin deficiency.
ZacksWhy Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insider Monkey15 Best ARK Stocks To Buy Now
In this article, we will take a look at the 15 best ARK stocks to buy now. To see more such companies, go directly to 5 Best ARK Stocks To Buy Now. Cathie Wood is one of the most polarizing, and prominent figures on Wall Street. With over three decades of experience in the financial sector, […]
